Provista Diagnostics Closes $5.25 Million Financing
21. März 2016 09:00 ET
|
Provista Diagnostics, Inc.
New York, March 21, 2016 (GLOBE NEWSWIRE) -- NEW YORK, NY – March 21, 2016 - Provista Diagnostics, Inc., a company developing and commercializing proteomic-based diagnostic, prognostic and...
Provista Diagnostics to Present at The 18th Annual BIO CEO & Investor Conference
08. Februar 2016 11:31 ET
|
Provista Diagnostics, Inc.
New York, NY, Feb. 08, 2016 (GLOBE NEWSWIRE) -- NEW YORK, NY – February 8, 2016 – Provista Diagnostics, Inc., today announces that David Reese, Ph.D., President and Chief Executive Officer, will...
Provista Diagnostics to Present at The 18th Annual BIO CEO & Investor Conference
08. Februar 2016 10:48 ET
|
Provista Diagnostics, Inc.
New York, NY, Feb. 08, 2016 (GLOBE NEWSWIRE) -- Provista Diagnostics, Inc., today announces that David Reese, Ph.D., President and Chief Executive Officer, will deliver a corporate overview at the...
Provista Diagnostics to Present at the 2015 Canaccord Genuity Medical Technology & Diagnostics Forum
18. November 2015 16:19 ET
|
Provista Diagnostics, Inc.
New York, NY, Nov. 18, 2015 (GLOBE NEWSWIRE) -- Provista Diagnostics, Inc., today announces that David Reese, Ph.D., President and Chief Executive Officer, will deliver a corporate overview at the...
Provista Diagnostics Offers Hope for the Early Detection of Breast Cancer in Women with Dense Breasts
29. September 2015 15:52 ET
|
Provista Diagnostics, Inc.
NEW YORK, NY, Sept. 29, 2015 (GLOBE NEWSWIRE) -- Provista Diagnostics, Inc. today announced that the data from two prospective, randomized, multi-center clinical studies, evaluating a novel...
Provista Diagnostics to Present at Leerink Global Healthcare Conference
09. Februar 2015 09:00 ET
|
Provista Diagnostics, Inc.
New York, NY, Feb. 9, 2015 (GLOBE NEWSWIRE) -- NEW YORK, NY - February 9, 2015: Provista
Diagnostics, Inc., a privately-held molecular diagnostics company
focused on developing and...